Delhi HC seeks Centre’s response on delay in safety review of acidity drug Ranitidine
The Delhi high court on Wednesday issued notice in a petition seeking directions to the Centre and its drug regulatory authorities to complete, within a stipulated time frame, the pending safety review of Ranitidine, a medication commonly used to treat acidity and reduce stomach acid
Read at Hindustan Times(opens in a new tab)
Full coverage
Delhi HC seeks Centre’s response on delay in safety review of acidity drug Ranitidine (opens Hindustan Times in a new tab)
In his petition, Jain contended that the safety of Ranitidine remained an unresolved concern since September 2019
HC seeks replies on plea to speed up Ranitidine safety review (opens Hindustan Times in a new tab)
The Delhi high court on Wednesday issued notice in a petition seeking directions to the Centre and its drug regulatory authorities to complete, within a stipulated time frame, the pending safety review of Ranitidine, a medication commonly used to treat…
